Kobo Biotech Ltd.
BSE: KOBO.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Neelam Kumar Murdia
- Employees
- 484
- Headquarters
- Mumbai, India
- IPO year
- 2024
- Market cap
- ₹64.6M
- Website
- http://www.kobobiotech.com
Loading KOBO…
Loading profile data…Frequently asked questions about KOBO
What does Kobo Biotech Ltd. (KOBO.BO) do?
Kobo Biotech Ltd. engages in the business of pharmaceuticals products. It focuses on manufacturing active pharmaceutical ingredients (API) based on fermentation technology. The company was founded on August 3, 1992 and is headquartered in Mumbai, India.
Where does KOBO.BO trade?
Kobo Biotech Ltd. (KOBO.BO) trades on the Bombay Stock Exchange.
What sector is KOBO.BO in?
Kobo Biotech Ltd. (KOBO.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Kobo Biotech Ltd.?
Neelam Kumar Murdia is the chief executive officer of Kobo Biotech Ltd. (KOBO.BO).
Where is Kobo Biotech Ltd. headquartered?
Kobo Biotech Ltd. is headquartered in India.
Does KOBO.BO pay a dividend?
Kobo Biotech Ltd. (KOBO.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KOBO.BO go public?
Kobo Biotech Ltd. (KOBO.BO) completed its initial public offering in 2024.